Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125840351 | 12584035 | 1 | I | 20160714 | 20160722 | 20160722 | EXP | GB-MYLANLABS-2016M1029629 | MYLAN | 0.00 | Y | 0.00000 | 20160722 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125840351 | 12584035 | 1 | PS | EPIRUBICIN | EPIRUBICIN | 1 | UNK | U | U | 91599 | |||||||||
| 125840351 | 12584035 | 2 | SS | ONDANSETRON | ONDANSETRON | 1 | UNK | U | U | 0 | |||||||||
| 125840351 | 12584035 | 3 | SS | APREPITANT. | APREPITANT | 1 | UNK | U | U | 0 | |||||||||
| 125840351 | 12584035 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | U | U | 0 | |||||||||
| 125840351 | 12584035 | 5 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | UNK | U | U | 0 | |||||||||
| 125840351 | 12584035 | 6 | SS | NEULASTA | PEGFILGRASTIM | 1 | UNK | U | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125840351 | 12584035 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125840351 | 12584035 | Alopecia | |
| 125840351 | 12584035 | Fatigue | |
| 125840351 | 12584035 | Headache | |
| 125840351 | 12584035 | Lower respiratory tract infection | |
| 125840351 | 12584035 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |